RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
HLS Therapeutics Stock

HLS Therapeutics P/E 2024

HLS Therapeutics P/E

-4.82

Ticker

HLS.TO

ISIN

CA40390B1094

WKN

A2JGH0

As of Aug 21, 2024, HLS Therapeutics's P/E ratio was -4.82, a 27.51% change from the -3.78 P/E ratio recorded in the previous year.

The HLS Therapeutics P/E history

HLS Therapeutics Aktienanalyse

What does HLS Therapeutics do?

HLS Therapeutics Inc. is a Canadian pharmaceutical company focused on the development and distribution of medical products in the North American market. It was founded in 2018 and is headquartered in Toronto, Canada. HLS Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering HLS Therapeutics's P/E Ratio

The Price to Earnings (P/E) Ratio of HLS Therapeutics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing HLS Therapeutics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of HLS Therapeutics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in HLS Therapeutics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about HLS Therapeutics stock

What is the price-to-earnings ratio of HLS Therapeutics?

The price-earnings ratio of HLS Therapeutics is currently -4.82.

How has the price-earnings ratio of HLS Therapeutics changed compared to last year?

The price-to-earnings ratio of HLS Therapeutics has increased by 27.51% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of HLS Therapeutics high compared to other companies?

Yes, the price-to-earnings ratio of HLS Therapeutics is high compared to other companies.

How does an increase in the price-earnings ratio of HLS Therapeutics affect the company?

An increase in the price-earnings ratio of HLS Therapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of HLS Therapeutics affect the company?

A decrease in the price-earnings ratio of HLS Therapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of HLS Therapeutics?

Some factors that influence the price-earnings ratio of HLS Therapeutics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does HLS Therapeutics pay?

Over the past 12 months, HLS Therapeutics paid a dividend of 0.2 USD . This corresponds to a dividend yield of about 8.58 %. For the coming 12 months, HLS Therapeutics is expected to pay a dividend of 0.18 USD.

What is the dividend yield of HLS Therapeutics?

The current dividend yield of HLS Therapeutics is 8.58 %.

When does HLS Therapeutics pay dividends?

HLS Therapeutics pays a quarterly dividend. This is distributed in the months of August, November, February, May.

How secure is the dividend of HLS Therapeutics?

HLS Therapeutics paid dividends every year for the past 0 years.

What is the dividend of HLS Therapeutics?

For the upcoming 12 months, dividends amounting to 0.18 USD are expected. This corresponds to a dividend yield of 7.9 %.

In which sector is HLS Therapeutics located?

HLS Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von HLS Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of HLS Therapeutics from 6/15/2023 amounting to 0.05 USD, you needed to have the stock in your portfolio before the ex-date on 4/27/2023.

When did HLS Therapeutics pay the last dividend?

The last dividend was paid out on 6/15/2023.

What was the dividend of HLS Therapeutics in the year 2023?

In the year 2023, HLS Therapeutics distributed 0.2 USD as dividends.

In which currency does HLS Therapeutics pay out the dividend?

The dividends of HLS Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von HLS Therapeutics

Our stock analysis for HLS Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of HLS Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.